Genetic testing for breast and ovarian cancer risk: The psychosocial issues. For some women, anticipating the diagnosis is worse than receiving the diagnosis itself

American Journal of Nursing

Volumn 102, Issue 12, 2002, Pages 40-47

  Pasacreta, Jeannie V ^a   Jacobs, Linda ^b   Cataldo, Janine K ^c  

^a YALE UNIVERSITY SCHOOL OF NURSING   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0040675779     PISSN: 0002936X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000446-200212000-00015     Document Type: Article

References (35)

1. Fasouliotis SJ, Schenker JG. BRCA1 and BRCA2 gene mutations: decision-making dilemmas concerning testing and management. Obstet Gynecol Surv 2000;55(6):373-84.
2. Bredart A, et al. Psychosocial dimensions of BRCA testing: an overshadowed issue. Eur J Cancer Care (Engl) 2001;10(2):96-9.
3. Croyle RT, Lerman C. Interest in genetic testing for colon cancer susceptibility: cognitive and emotional correlates. Prev Med 1993;22(2):284-92.
4. Burke W, et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA 1997;277(12):997-1003.
5. Goodwin PJ. Management of familial breast cancer risk. Breast Cancer Res Treat 2000;62(1):19-33.
6. Grann VR, et al. Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients. J Clin Oncol 1998;16(3):979-85.
7. Chaliki H, et al. Women's receptivity to testing for a genetic susceptibility to breast cancer. Am J Public Health 1995;85(8):1133-5.
8. Lerman C, et al. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 1994;12(4):843-50.
9. Struewing JP, et al. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol Biomarkers Prev 1995;4(2):169-73.
10. Andrykowski MA, et al. Interest in learning of personal genetic risk for cancer: a general population survey. Prev Med 1996;25(5):527-36.
11. Cappelli M, et al. Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer. Clin Genet 1999;55(6):419-30.
12. Lerman C, Croyle R. Psychological issues in genetic testing for breast cancer susceptibility. Arch Intern Med 1994;154(6):609-16.
13. Lerman C, Croyle RT. Genetic testing for cancer predisposition: behavioral science issues. J Natl Cancer Inst Monogr 1995;17:63-6.
14. Lerman C, et al. BRCA1 testing in families with hereditary breast-ovarian cancer: a prospective study of patient decision making and outcomes. JAMA 1996;275(24):1885-92.
15. Meijers-Heijboer EJ, et al. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet 2000;355(9220):2015-20.
16. Armstrong K, et al. Factors associated with decisions about clinical BRCA1/2 testing. Cancer Epidemiol Biomarkers Prev 2000;9(11):1251-4.
17. Lerman C, et al. The influence of psychological distress on use of genetic testing for cancer risk. J Consult Clin Psychol 1997;65(3):414-20.
18. Smith KR, et al. Familial context of genetic testing for cancer susceptibility: moderating effect of siblings' test results on psychological distress one to two weeks after BRCA1 mutation testing. Cancer Epidemiol Biomarkers Prev 1999;8 (4 Pt 2):385-92.
19. Bluman LG, et al. Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2. J Clin Oncol 1999;17(3):1040-6.
20. Biesecker BB, et al. Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families. Am J Med Genet 2000;93(4):257-63.
21. Lerman C, et al. What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing. J Clin Oncol 1998;16(5):1650-4.
22. Lynch HT, et al. DNA screening for breast/ovarian cancer susceptibility based on linked markers: a family study. Arch Intern Med 1993;153(17):1979-87.
23. Lerman C, et al. Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet 1995;57(3):385-92.
24. Wagner TM, et al. Attitude towards prophylactic surgery and effects of genetic counseling in families with BRCA mutations. Br J Cancer 2000;82(7):1249-53.
25. Baum A, et al. Stress and genetic testing for disease risk. Health Psychol 1997;16(1):8-19.
26. Ritvo P, et al. Psychological adjustment to familial genetic risk assessment: differences in two longitudinal samples. Patient Educ Couns 2000;40(2):163-72.
27. Schwartz MD, et al. Coping disposition, perceived risk, and psychological distress among women at increased risk for ovarian cancer. Health Psychol 1995;14(3):232-5.
28. Compas BE, et al. When mom or dad has cancer: markers of psychological distress in cancer patients, spouses, and children. Health Psychol 1994;13(6):507-15.
29. Kash KM, et al. Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 1992;84(1):24-30.
30. Lerman C, et al. Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst 1993;85(13):1074-80.
31. Lerman C, et al. Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior. J Natl Cancer Inst Monogr 1994;16:171-6.
32. Rosenthal G, et al. The Strang National High Risk Registry: a program for delivery of cancer risk information and a resource for research. Ann N Y Acad Sci 1995;768:317-22.
33. Julian-Reynier C, et al. Attitudes towards cancer predictive testing and transmission of information to the family. J Med Genet 1996;33(9):731-6.
34. Hamann HA, et al. Attitudes toward the genetic testing of children among adults in a Utah-based kindred tested for a BRCA1 mutation. Am J Med Genet 2000;92(1):25-32.
35. Sharpe NF. Psychological aspects of genetic counseling: a legal perspective. Am J Med Genet 1994;50(3):234-8.